Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Ilyas-Feldmann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Seizure|February 22, 2021
Long-term seizure outcome and antiseizure medication use in autoimmune encephalitisMaria Ilyas-Feldmann, Harald Prüß, Martin Holtkamp
Der Nervenarzt|March 7, 2024
[Epilepsy and pregnancy]Verena Gaus, Maria Ilyas-Feldmann, Bettina Schmitz
Der Nervenarzt|September 7, 2021
[Imaging in the presurgical evaluation of epilepsy]Maria Ilyas-Feldmann, Bernd Vorderwülbecke, Mirja Steinbrenner
Der Nervenarzt|July 18, 2024
[Discontinuation of antiseizure medication in patients with epilepsy]Maria Ilyas-Feldmann, Luise Graf, Thea Hüsing, et al.
Epilepsia|June 29, 2024
Risk of breakthrough seizures depends on type and etiology of epilepsyJakob I Doerrfuss, Luise Graf, Thea Hüsing, et al.
European Journal of Neurology|November 28, 2023
Non-discontinuation of antiseizure medication in seizure-free epilepsy patientsJakob I Doerrfuss, Thea Hüsing, Luise Graf, et al.
Epilepsia|February 15, 2022
Utility of 18F-fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: A multicenter studyMirja Steinbrenner, John S Duncan, John Dickson, et al.
Epilepsia|June 26, 2025
Non-discontinuation of antiseizure medication in seizure-free patients with epilepsy: Reasons and predictors among neurologists and patientsMaria Ilyas-Feldmann, Luise Graf, Jakob I Doerrfuss, et al.
Seizure|May 22, 2024
Tolerability of tariquidar - A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsyMaria Ilyas-Feldmann, Oliver Langer, Martin Bauer, et al.
Epilepsia|July 7, 2020
P-glycoprotein overactivity in epileptogenic developmental lesions measured in vivo using (R)-[<sup>11</sup> C]verapamil PETMaria Ilyas-Feldmann, Marie-Claude Asselin, Shaonan Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Seizure|February 22, 2021
Long-term seizure outcome and antiseizure medication use in autoimmune encephalitisMaria Ilyas-Feldmann, Harald Prüß, Martin Holtkamp
Der Nervenarzt|March 7, 2024
[Epilepsy and pregnancy]Verena Gaus, Maria Ilyas-Feldmann, Bettina Schmitz
Der Nervenarzt|September 7, 2021
[Imaging in the presurgical evaluation of epilepsy]Maria Ilyas-Feldmann, Bernd Vorderwülbecke, Mirja Steinbrenner
Der Nervenarzt|July 18, 2024
[Discontinuation of antiseizure medication in patients with epilepsy]Maria Ilyas-Feldmann, Luise Graf, Thea Hüsing, et al.
Epilepsia|June 29, 2024
Risk of breakthrough seizures depends on type and etiology of epilepsyJakob I Doerrfuss, Luise Graf, Thea Hüsing, et al.
European Journal of Neurology|November 28, 2023
Non-discontinuation of antiseizure medication in seizure-free epilepsy patientsJakob I Doerrfuss, Thea Hüsing, Luise Graf, et al.
Epilepsia|February 15, 2022
Utility of 18F-fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: A multicenter studyMirja Steinbrenner, John S Duncan, John Dickson, et al.
Epilepsia|June 26, 2025
Non-discontinuation of antiseizure medication in seizure-free patients with epilepsy: Reasons and predictors among neurologists and patientsMaria Ilyas-Feldmann, Luise Graf, Jakob I Doerrfuss, et al.
Seizure|May 22, 2024
Tolerability of tariquidar - A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsyMaria Ilyas-Feldmann, Oliver Langer, Martin Bauer, et al.
Epilepsia|July 7, 2020
P-glycoprotein overactivity in epileptogenic developmental lesions measured in vivo using (R)-[<sup>11</sup> C]verapamil PETMaria Ilyas-Feldmann, Marie-Claude Asselin, Shaonan Wang, et al.
Pageof 2